The short answer
GHK coordinates copper(II) through its N-terminal amine, the adjacent backbone nitrogen and the histidine imidazole. That three-nitrogen arrangement is a well-characterised motif for binding divalent metals, and binding displaces a proton, which is why the complex is 62.54 Da heavier rather than 63.55.
Key facts
- Coordinating atoms
- N-terminal amine, backbone N, imidazole N
- Metal
- Copper(II)
- Proton displaced
- One
- Mass change
- +62.54 Da
- Visible signature
- Blue colour
- Motif name
- ATCUN-type (amino-terminal Cu/Ni binding)
The binding motif
GHK's arrangement (a free N-terminal amine, a histidine at position three, and the backbone nitrogens between them) is an example of the amino-terminal copper and nickel binding motif. The same arrangement appears at the N-terminus of human serum albumin, which is not a coincidence: GHK was isolated from the albumin fraction of plasma, and its copper-binding chemistry is of the same type.
Why three nitrogens
Copper(II) prefers four-coordinate square-planar geometry. Three nitrogen donors from the peptide plus a fourth coordination position gives a stable, well-defined complex. Nitrogen donors bind copper more tightly than oxygen, which is why a histidine-containing motif outcompetes arrangements built from carboxylates.
Research material referenced
GHK-Cu 100mg, third-party HPLC tested
The displaced proton
A backbone amide nitrogen normally carries a hydrogen and is a poor metal donor. Deprotonating it turns it into a strong one. Copper binding therefore drives loss of that proton, and the resulting complex is one hydrogen lighter than simple addition would predict. This is the chemistry behind the 62.54 Da mass difference and it is a general feature of this binding motif rather than something peculiar to GHK.
Why affinity matters biologically
The framing of GHK as a copper carrier depends on it binding copper tightly enough to hold it in transit and loosely enough to release it where needed. That balance, high affinity but reversible, is what distinguishes a transport molecule from a chelator that simply sequesters a metal. It is also why the copper is described as delivered rather than removed.
The colour is diagnostic
Copper(II) complexes absorb in the red part of the spectrum and appear blue. The intensity and exact shade depend on the coordination environment, so colour is a real qualitative indicator that copper is bound in the expected geometry rather than merely present in the vial.
Frequently asked questions
- Which residues bind the copper?
- The N-terminal amine of glycine, the backbone nitrogen between glycine and histidine, and the histidine imidazole nitrogen: a three-nitrogen donor set.
- Why does binding displace a proton?
- A backbone amide nitrogen must be deprotonated to act as a strong metal donor. That loss is why the complex is 62.54 Da heavier rather than 63.55.
- Is GHK's motif unique?
- No. It is an ATCUN-type site, the same class found at the N-terminus of human serum albumin, from which GHK was originally isolated.
Extended research context
The GHK-Cu (Copper Peptide) deep dive
Deep dive: why the copper ion matters
The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically. Nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.
GHK-Cu in the transcriptomic literature
The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses, including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.
Analytical fingerprinting of GHK-Cu
On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.
Research applications
- ▸In vitro fibroblast and keratinocyte gene-expression studies
- ▸ECM turnover assays (collagen, elastin, decorin, MMP profiling)
- ▸Wound-healing scratch assays in cell culture models
- ▸Antioxidant-mechanism studies (copper redox modulation)
- ▸Formulation R&D: cosmetic and topical carrier compatibility research
Handling checklist
- ✓Store lyophilised vial at 2–8 °C, protected from light
- ✓Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
- ✓Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
- ✓Aliquot reconstituted solution for freeze/thaw minimisation
- ✓Verify blue colour and CoA HPLC ≥98% before use
Common research-handling mistakes
Learnt from thousands of researcher orders across our UK labs.
✗ Buying GHK without copper
Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.
✗ Mixing with vitamin C in solution
Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex, keep them separate.
✗ Exposing to sunlight
Fix: Store in amber vial or foil-wrapped container at 2–8 °C.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Related questions researchers ask
- Is GHK-Cu the same as copper peptide?
- What does GHK-Cu do in research studies?
- Is GHK-Cu safe for topical formulation research?
- What concentration of GHK-Cu is used in cell culture?
- How is GHK-Cu different from GHK alone?
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubChemPubChem · GHK-Cu copper complex (CID 71587328)pubchem.ncbi.nlm.nih.gov
- PubMedPickart L, The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed 2008 (PMID 18644225)pubmed.ncbi.nlm.nih.gov
- PubMedPubMed: GHK copper binding literaturepubmed.ncbi.nlm.nih.gov
- PubMedPickart L & Margolina A, GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int 2015 (PMID 26236730)pubmed.ncbi.nlm.nih.gov
- PubMedPickart L et al., The Effect of the Human Peptide GHK on Gene Expression. Brain Sci 2017 (PMID 28212278)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · Glycyl-L-histidyl-L-lysine (CID 73587)pubchem.ncbi.nlm.nih.gov
- PubMedNIH PubMed: GHK-Cu wound healing literaturepubmed.ncbi.nlm.nih.gov
- GuidelineGoogle: Creating helpful, reliable, people-first contentdevelopers.google.com
Written and reviewed by
The UK Peptides Editorial Team · Research library, UK Peptides
The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.
More GHK-Cu (Copper Peptide) articles
- How GHK Was DiscoveredPickart found that plasma from young donors changed protein synthesis in older liver tissue. The active fraction was a tripeptide, isolated in 1973.
- The 4,000 Genes Claim, ExaminedPickart and Margolina reported GHK modulating over 4,000 human genes using the Broad Institute Connectivity Map. What that measures, and what it does not.
- GHK-Cu Mechanism: What Is Actually ProposedThe dominant proposal is copper delivery to enzymes requiring it as a cofactor. What that explains, what it does not, and why no receptor is established.
- GHK-Cu and Collagen Synthesis ResearchLysyl oxidase requires copper to cross-link collagen. That enzyme dependency is the clearest mechanistic route from GHK-Cu to matrix effects in the literature.
- GHK-Cu and Matrikine SignallingMatrikines are peptide fragments released from matrix proteins that signal back to cells. Whether GHK qualifies is a proposed framing rather than a settled one.
Popular across the research hub
One flagship guide from every other research category.
- Retatrutide ResearchWhat "Reta" on a Label Actually Tells You
- TB-500 (Thymosin β4 fragment)TB-500: Names, Spellings and What Each Finds
- BPC-157 (Pentadecapeptide)BPC-157 vs TB-500 Compared
- CJC-1295 & IpamorelinWhat Is CJC-1295? The Two Forms and Their Masses
- Peptide ReferenceOligopeptide, Polypeptide, Protein
- Bacteriostatic WaterBacteriostatic Water: Shelf Life, Storage and the 28-Day Rule
- Research & Regulatory NewsRetatrutide TRIUMPH-2 and TRIUMPH-3: What They Added
- GLP-1 & Incretin ScienceGlucagon-Containing Dual Agonists: Survodutide and Mazdutide
- MOTS-c (Mitochondrial Peptide)MOTS-c Nuclear Translocation Under Metabolic Stress
- Semax (ACTH Fragment Peptide)Semax Mechanism: Neurotrophin Expression
- Selank (Tuftsin Analogue)Selank and BDNF: What the Studies Measured
- DSIP (Delta Sleep-Inducing Peptide)What Is DSIP? The Nonapeptide Named for an EEG Effect
- KLOW (Blend)What Is KLOW? KPV, GHK-Cu, BPC-157 and TB-500
- GLOW (Blend)What Is GLOW? GHK-Cu, BPC-157 and TB-500
- MT-2 (Melanotan II)Why This Site Publishes No Melanotan 2 Dose
- IGF-1 LR3What Is IGF-1 LR3? Why It Is a Protein, Not a Peptide
- GlutathioneWhat Is Glutathione? The Bond That Makes It Unusual
- NAD+What Is NAD+? Structure, Role, and Why It Is Not a Peptide
- KPVWhat Is KPV? The Tripeptide From Alpha-MSH